Lumen

Ramat Hasharon, Israel Founded: 2014 • Age: 12 yrs
Breath-based metabolism tracker for personalized diet plans is provided.

About Lumen

Lumen is a company based in Ramat Hasharon (Israel) founded in 2014 by Merav Mor, Avi Smila, Michal Mor, Daniel Tal, and Dror Ceder. It operates as a Direct-to-Consumer (D2C). Lumen has raised $77.5 million across 4 funding rounds from investors including Hanwha, H&H Group and Pitango. Lumen offers products and services including Lumen Device. Lumen operates in a competitive market with competitors including Tyto Care, Endotronix, Edwards Lifesciences, BioIntelliSense and Oxehealth, among others.

  • Headquarter Ramat Hasharon, Israel
  • Founders Merav Mor, Avi Smila, Michal Mor, Daniel Tal, Dror Ceder
  • Sectors
    Healthcare
    Technology
  • Website category Health · Nutrition Diets and Fitness
  • Website lumen.me
  • Social LinkedIn X Facebook Instagram YouTube
  • Legal Name Metaflow Ltd.
Key Metrics
  • Total Equity Funding
    $77.5M (USD)

    in 4 rounds

  • Latest Funding Round
    $62M (USD), Series B

    Dec 2022

  • Investors
    Hanwha

    & 13 more

Products & Services of Lumen

Lumen offers a comprehensive portfolio of products and services, including Lumen Device.

Lumen Device
Health Technology

A handheld device measuring metabolism through breath analysis.

Apps and channels of Lumen

Lumen publishes 1 mobile app with over 100K+ downloads; its YouTube channel Lumen has 12.6K subscribers and 30 videos.

Lumen - Metabolic Coach
Google Play Health & Fitness Everyone Free 100K+ downloads
Developer: Lumen.me
View on Google Play
Lumen
YouTube 12.6K subscribers 30 videos Howto & Style
Open channel

Videos from Lumen

The most watched videos on Lumen's YouTube channel, Lumen (12.6K subscribers). Click a video to play it here.

"Game-changer" | Lumen Review 1 Year Later
87.5K views
Lumen review: 1 year later
23K views
Managing Menopause & Losing 50 Pounds | Maria’s Journey From Health Crisis to Comeback
12.7K views
Lumen Review | 7 Weeks In
10K views

More on Lumen.

Funding Insights of Lumen

Lumen has successfully raised a total of $77.5M across 4 strategic funding rounds. The most recent funding activity was a Series B round of $62 million completed in December 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $77.5M
  • Total Rounds 4
  • Last Round Series B β€” $62M
  • Investors Count 14

All 4 funding rounds of Lumen with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Dec 2022$62MSeries B–Pitango
Sep 2019$8.5MSeries B–H&H Group, Unorthodox Ventures
Jul 2018$7MSeries A–Resolute Ventures, Red Swan Ventures
Nov 2017–Seed–Novadea
–
Valuation history

14 investors in total: 10 institutional and 4 angel.

Investors in Lumen

Lumen has secured backing from 14 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include Hanwha, H&H Group and Pitango.

All
Venture Fund
Institutional
Angel
InvestorDescriptionFounded YearDomainLocation
Venture capital investments in tech and healthtech sectors through dedicated funds.
–pitango.com-
Early-stage venture capital funding is provided to founders.
–resolute.vcSan Francisco, United States
Venture capital firm backed by RiverPark Funds group
–riverparkvc.comNew York, United States
Early-stage investments are made in medical and construction technology.
–unorthodoxventures.comAustin, United States
Investments in health tech sectors are managed by Almeda Ventures.
–almedaventures.comTel Aviv, Israel
Seed & early stage tech-focused VC firm investing primarily in the US and Israel
–disruptivevc.comHerzliya, Israel
Tech focused VC firm investing in early stage companies in the US
–redswan.vcNew York, United States
-
–novadea.com-
Manufacturer of solar cells, modules, and other related components
1952hanwha.comSeoul, South Korea
Supplier of nutrition and wellness products
1999hh.globalHong Kong, China
Premium access

Investor details for Lumen

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Lumen

13 people are tracked at Lumen (9 in leadership, 4 in team).

NameRoleGroup
Merav Mor
Co-FounderLeadership
Avi Smila
Co-FounderLeadership
Michal Mor
Co-Founder & Head of Science for ProductLeadership
Daniel Tal
Co-Founder & Co-CEOLeadership
Dror Ceder
Co-FounderLeadership
Eliran Falah
Co-CEOLeadership
Daniel Tal Mor
Founder & CEOLeadership
Nitzan Wizman
PA To CEOLeadership
Adi Bar-Oz
VP Of HRLeadership
Hagar Cohen
General CounselTeam
Michal Fiala
Payroll controllerTeam
Sophia Cohen
Influencer & Affiliate PartnershipsTeam
Maya Listman
Influencer Marketing ManagerTeam
Premium access

Complete people profiles for Lumen

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Lumen

3 dated milestones of Lumen across 8 years, from founding to its latest funding, stage changes and deals.

  1. Founded Lumen is founded.
  2. Funding First funding round.
  3. Funding Latest funding round, Series B, of $62.0M.

Competitors of Lumen

Lumen operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Tyto Care, Endotronix, Edwards Lifesciences, BioIntelliSense and Oxehealth, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
tytocare.com2011Netanya, Israel$199.5M–
Medical consultations are facilitated via self-exams and remote diagnostic devices.
endotronix.com2007East Peoria, United States$154.77M104
Miniaturized wireless implantable sensors are developed for hemodynamic monitoring.
edwards.com1958Irvine, United States–19,800
Medical devices for structural heart disease are developed and provided.
biointellisense.com2018Redwood, United States$82M26
Vital signs are monitored via a single-use patch and platform.
oxehealth.com2012Leeds, United Kingdom$7.14M95
Contactless patient monitoring is provided for mental health facilities.
coachcare.com2013New York, United States$60.2M–
Remote monitoring platform for tracking patient activity
higi.com2012Chicago, United States$95.23M53
Gamified app for personal health management
cardionet.com1999Conshohocken, United States$141.9M–
Outpatient cardiac arrhythmia monitoring solutions are provided by CardioNet.
bodymedia.com1999Pittsburgh, United States$27.55M–
Physiological data is captured by wearable monitors for health monitoring.
Premium access

Detailed competitors of Lumen

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Lumen

The website of Lumen (lumen.me) receives about 260.1K visits a month and ranks #216,317 among all websites worldwide, #7,084 in Nutrition Diets and Fitness.

  • Monthly visits
    260.1K

    ▲ 19.7% vs previous month

  • Unique visitors
    116.6K

    per month

  • Global rank
    #216,317

    among all websites

  • Category rank
    #7,084

    Health · Nutrition Diets and Fitness

Similar websites

Websites whose visitors overlap most with Lumen. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
resona.health
resona.health
100%
–#680,677–
noom.com
97%
3M#15,405View details
innosupps.com
innosupps.com
95%
–#152,330–
myfooddiary.com
93%
–#174,762View details
futurhealth.com
93%
10.7K#4,145,713View details
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 28 similar websites and full traffic analytics for Lumen

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 28 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Latest news on Lumen

Premium access

Complete news archive for Lumen

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Similar companies to Lumen

10 companies that operate in the same segment as Lumen (Obesity), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Satiety induction through digestable gastric balloon introduced via a swallowed capsule
2009Wellesley, Massachusetts, United StatesUSD 174.04 MUSD 32.11 M137
Therapeutics for diabetes and obesity treatment are developed.
2005Lyon, Auvergne-rhone-alpes, FranceUSD 26 MUSD 1.74 M77
Bioinformatics platform is provided for biomarkers and drug discovery.
2015Vallejo, California, United StatesUSD 293.9 MUSD 8.99 M64
Disease-modifying therapies for metabolic diseases are developed.
2008Berkeley, California, United StatesUSD 385.52 M––
Oral small molecule drugs for chronic diseases are developed.
2017San Francisco, California, United StatesUSD 233 M–163
Small molecule therapeutics for obesity and metabolic disorders are developed.
2017San Diego, California, United StatesUSD 138 M–22
Therapeutic devices for obesity and GI disorders are developed.
2005Austin, Texas, United StatesUSD 80.36 MUSD 76.86 M132
Nonsurgical endoscopic devices for GI tract anastomoses are developed.
2012West Bridgewater, Massachusetts, United StatesUSD 91.98 M–15
Biopharmaceuticals for obesity and metabolic diseases are developed.
2022New York, New York, United StatesUSD 505 M–81
Technology for oral delivery of large drug molecules is developed.
2012San Jose, California, United StatesUSD 234.14 MUSD 1.63 M105
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Lumen

Lumen was founded in 2014 and raised its 1st funding round 3 years after it was founded.

Lumen is headquartered in Ramat Hasharon, Israel. It is registered at Ramat Hasharon, Tel Aviv District, Israel.

Daniel Tal is the current CEO of Lumen. They have also founded this company.

Lumen is a funded company, having raised a total of $77.5M across 4 funding rounds to date.

Lumen is known for creating the worlds first handheld metabolic coach, focusing on real-time metabolism tracking through breath analysis. Solutions are provided for improving nutrition, exercise, sleep, and stress levels. The company collaborates with top institutions for innovative research in metabolic health. Services are tailored for individuals seeking weight management, energy boosts, and overall wellness. Data-driven insights are offered to both practitioners and patients in the healthcare sector.

Lumen's top competitors include Tyto Care, Endotronix and Oxehealth.

Lumen offers Lumen Device.

Lumen has 14 investors. Key investors include Hanwha, H&H Group, Pitango, Resolute Ventures, and RiverPark Ventures.

Lumen operates through Metaflow Ltd..

Yes. Lumen publishes Lumen - Metabolic Coach, with over 100,000 downloads.

The website of Lumen receives about 260 thousand visits a month and ranks #216,317 among all websites worldwide.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available